BMRN fund manager activity
BioMarin Pharmaceutical Inc · Nasdaq. Reported by 9 tracked fund managers in their 13F filings, Q1 2014 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Dodge & Cox Funds | Added | 14,844,930 | $849,426,895 | 0.44% | Aug 13, 2026 |
| Ken Fisher - Fisher Asset Management | Trimmed | 35,389 | $2,024,997 | 0.00% | Aug 4, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 28,641 | $1,638,838 | 0.00% | Aug 14, 2026 |
| Torray Funds | Trimmed | 77,705 | $4,446,280 | 0.60% | Jul 30, 2026 |
| Viking Global Investors | Added | 7,616,563 | $435,819,735 | 1.24% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Dodge & Cox Funds | Trimmed | 14,561,759 | $822,593,766 | 0.45% | May 14, 2026 |
| Ken Fisher - Fisher Asset Management | Added | 35,480 | $2,004,282 | 0.00% | May 5, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 174,091 | $9,834,401 | 0.03% | May 15, 2026 |
| Torray Funds | New | 78,170 | $4,415,823 | 0.65% | May 1, 2026 |
| Viking Global Investors | Added | 7,062,077 | $398,936,730 | 1.12% | May 15, 2026 |
Older quarters